CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Bupivacaine %0.25 (isobaric) +1 moredrug
Likely dose
Bupivacaine %0.25 (isobaric) 20 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07458321
NCT07458321N/ACompleted

THE EFFECT OF EPIDURAL ANESTHESIA ON OPTIC NERVE SHEATH DIAMETER MEASUREMENTS IN TOTAL KNEE PROSTHESIS SURGERY WITH NEURAXIAL ANESTHESIA: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY

Bursa City Hospital·interventional·Posted Mar 9, 2026·Updated Mar 9, 2026

In Brief

A clinical study evaluating Bupivacaine %0.25 (isobaric) and Bupivacaine %0.5 (hyperbaric) for Total Knee Replacement and 2 related conditions. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study investigates the effects of epidural anesthesia on intracranial pressure (ICP) by using ultrasonographic optic nerve sheath diameter (ONSD) measurements as a non-invasive indicator. The study aims to determine if the volume of local anesthetic applied to the epidural space during total knee replacement surgery leads to transient increases in ONSD compared to spinal anesthesia. Participants are randomized into two groups to receive either epidural or spinal anesthesia, and their ONSD measurements are tracked before, during, and after the surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMar 9, 2026
Enrollment StartDec 6, 2023
Primary CompletionJan 6, 2024
Study CompletionApr 20, 2024
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 4 months ago

Interventions

Bupivacaine %0.25 (isobaric)drug

in epidural group A total volume of 20 ml of 0.25% bupivacaine is administered into the epidural space.

Bupivacaine %0.5 (hyperbaric)drug

in spinal group A dose of 15 mg (3 ml) of 0.5% heavy bupivacaine is administered into the subarachnoid space.